drugset / Trial / NCT04406129

Effect of Gut Microbiome Restoration on Primary Hypertension Via FMT

NCT04406129 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Mounting preclinical and clinical evidences have proved the causal role of gut microbiota on the pathogenesis of primary hypertension. Restoration of gut microbiota ameliorated high BP in rodents and/or human cases.A hypothesis is thus raised that gut microbiome restoration can be a potential approach to ameliorate hypertension. This pilot study will utilize fecal microbiota transplantation (FMT) capsules, in comparison with placebo capsules, to investigate the effect, safety and underlying mechanisms of gut microbiome restoration on primary hypertension.

Timeline

Start
2021-03-17
Primary completion
2022-02-01
Completion
2022-09-01

Outcome

Missed primary endpoint

paper the primary outcome (6.28 (11.83) vs. 5.77 (10.06) mmHg, p = 0.62) were comparable between the groups. PMID 40410854 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject fecal microbiota transplantation Other / unclassified — Oral